Translation

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Consolidated Financial Results

for the Year Ended December 31, 2021

(Based on Japanese GAAP)

February 10, 2022

Company name:

Euglena Co., Ltd.

Stock exchange listing:

Tokyo

Stock code:

2931

URL

http://www.euglena.jp/

Representative:

Representative Director, President

Mitsuru Izumo

Inquiries:

Executive Officer, CFiO

Tomohiro Wakahara

TEL

03(3454)4907

Scheduled date of ordinary general meeting of shareholders:

March 26, 2022

Scheduled date to file Securities Report:

March 28, 2022

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on financial results:

Yes

Holding of financial results meeting:

Yes

(for analysts and institutional investors)

(Amounts less than one million yen are rounded down)

1. Consolidated financial results for the year ended December 31, 2021 (from October 1, 2020 to December 31, 2021)

(1) Consolidated operating results

Percentages indicate year-on-year changes

Net sales

Adjusted EBITDA*

Operating profit

Ordinary profit

Profit attributable

to owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Year ended December 31, 2021

34,420

-

1,368

-

(6,565)

-

(6,354)

-

(5,038)

-

Year ended September 30, 2020

13,317

(4.7)

(732)

-

(1,807)

-

(1,457)

-

(1,486)

-

  • Because management has shifted its focus to cash flow management, the Company now presents adjusted EBITDA as a key performance indicator to show its capacity for generating free cash flows.

Note 1: Comprehensive income Year ended December 31, 2021

¥(5,853)

million

[-%]

Year ended September 30, 2020

¥(1,483)

million

[-%]

Note 2: The fiscal year ended December 31, 2021 is an irregular 15-month period due to the change in the fiscal year end. Consequently, year- on-year changes are not presented.

Earnings per share

Diluted earnings per

Profit attributable to

Ordinary profit/total

Operating profit/net

share

owners of

assets

sales

parent/equity

Yen

Yen

%

%

%

Year ended December 31, 2021

(49.07)

-

(34.1)

(16.5)

(19.1)

Year ended September 30, 2020

(16.00)

-

(14.7)

(9.0)

(13.6)

Reference: Share of profit (loss) of entities accounted for using equity method

Year ended December 31, 2021

¥58 million

Year ended September 30, 2020

¥(27) million

(2) Consolidated financial position

Total assets

Net assets

Equity ratio

Net assets per share

Millions of yen

Millions of yen

%

Yen

As of December 31, 2021

61,007

20,588

33.0

181.35

As of September 30, 2020

15,351

9,386

61.0

100.58

Reference: Equity

As of December 31, 2021

¥20,355 million

As of September 30, 2020

¥9,363 million

(3) Consolidated cash flows

Cash flows from

Cash flows from

Cash flows from

Cash and cash equivalents

operating activities

investing activities

financing activities

at end of period

Millions of yen

Millions of yen

Millions of yen

Millions of yen

Year ended December 31, 2021

1,378

(10,338)

12,062

9,820

Year ended September 30, 2020

(1,217)

(350)

162

6,253

1

2. Cash dividends

Annual dividends per share

Total cash

Dividend payout

Ratio of dividends

to net assets

1st quarter-end

2nd quarter-end

3rd quarter-end

4th quarter-end

Fiscal year-end

Total

dividends (Total)

ratio (Consolidated)

(Consolidated)

Yen

Yen

Yen

Yen

Yen

Yen

Millions of yen

%

%

Year ended September 30, 2020

-

0.00

-

-

0.00

0.00

-

-

-

Year ended December 31, 2021

-

0.00

-

-

0.00

0.00

-

-

-

Year ending December 31, 2022

-

0.00

-

-

0.00

0.00

-

(Forecast)

3. Forecast of consolidated financial results for the year ending December 31, 2022 (from January 1, 2022 to December 31, 2022)

Percentages indicate year-on-year changes

Net sales

Adjusted EBITDA*

Operating profit

Ordinary profit

Profit attributable to

Earnings per

owners of parent

share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

48,000

-

2,100

-

-

-

-

-

-

-

-

Reference: Adjusted EBITDA = EBITDA (Operating profit + Amortization of goodwill and Depreciation) + Subsidy income + Stock-related remuneration + Inventory step-up effect.

4. Notes

(1)

Changes in significant subsidiaries during the year ended December 31, 2021

Yes

(changes in specified subsidiaries resulting in the change in scope of consolidation):

(2)

Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

No

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

(3) Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

As of December 31, 2021

111,161,886

shares

As of September 30, 2020

93,153,322

shares

Number of treasury shares at the end of the period

As of December 31, 2021

20,431

shares

As of September 30, 2020

56,459

shares

Average number of shares during the period

Year ended December 31, 2021

102,692,699

shares

Year ended September 30, 2020

92,900,464

shares

  • Financial results reports are exempt from review conducted by certified public accountants or an audit corporation.
  • Proper use of financial results forecast, and other special matters
    The forward-looking statements, including the earnings forecasts, shown in this document are based on information currently available to the Company and on certain assumptions deemed to be reasonable.

2

Consolidated financial statements

Consolidated balance sheets

(Thousands of yen)

As of September 30, 2020

As of December 31, 2021

Assets

Current assets

Cash and deposits

6,253,900

9,900,624

Notes and accounts receivable - trade

1,076,070

3,182,255

Securities

-

285,340

Merchandise and finished goods

805,920

4,572,465

Work in process

44,636

744,762

Raw materials and supplies

949,842

1,144,292

Other

669,477

673,020

Allowance for doubtful accounts

(8,292)

(64,383)

Total current assets

9,791,554

20,438,377

Non-current assets

Property, plant and equipment

Buildings and structures

3,068,137

7,314,680

Machinery, equipment and vehicles

1,488,471

3,375,030

Tools, furniture and fixtures

391,575

1,396,667

Land

900,520

2,499,773

Leased assets

25,946

109,588

Construction in progress

6,253

5,457

Accumulated depreciation

(2,576,423)

(7,849,249)

Total property, plant and equipment

3,304,480

6,851,949

Intangible assets

Goodwill

961,239

13,034,671

Customer-related assets

285,941

17,011,026

Other

312,416

1,858,079

Total intangible assets

1,559,597

31,903,777

Investments and other assets

Investment securities

319,946

397,252

Guarantee deposits

283,979

317,686

Deferred tax assets

8,291

740,246

Other

83,248

395,616

Allowance for doubtful accounts

-

(37,173)

Total investments and other assets

695,465

1,813,629

Total non-current assets

5,559,543

40,569,356

Total assets

15,351,098

61,007,734

3

(Thousands of yen)

As of September 30, 2020

As of December 31, 2021

Liabilities

Current liabilities

Notes and accounts payable - trade

260,402

1,082,104

Short-term borrowings

547,425

2,287,746

Accounts payable - other

935,975

3,715,753

Lease obligations

291

8,898

Income taxes payable

8,500

486,483

Provision for bonuses

28,800

267,344

Provision for point card certificates

22,200

1,202,169

Provision for business restructuring

-

31,319

Asset retirement obligations

24,620

-

Other

332,185

1,552,228

Total current liabilities

2,160,401

10,634,047

Non-current liabilities

Long-term borrowings

3,216,532

22,598,636

Lease obligations

24

14,285

Provision for retirement benefits for directors (and other

-

52,647

officers)

Retirement benefit liability

19,839

390,482

Asset retirement obligations

399,080

427,027

Deferred tax liabilities

164,805

6,297,173

Other

3,656

4,574

Total non-current liabilities

3,803,938

29,784,827

Total liabilities

5,964,339

40,418,874

Net assets

Shareholders' equity

Share capital

7,323,548

13,888,478

Capital surplus

2,229,643

11,602,445

Retained earnings

(84,993)

(5,273,240)

Treasury shares

(94,737)

(34,282)

Total shareholders' equity

9,373,460

20,183,400

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

(1,802)

(2,121)

Foreign currency translation adjustment

(8,227)

(20,625)

Remeasurements of defined benefit plans

-

(5,035)

Total accumulated other comprehensive income

(10,029)

(27,782)

Share acquisition rights

13,556

427,696

Non-controlling interests

9,771

5,545

Total net assets

9,386,758

20,588,859

Total liabilities and net assets

15,351,098

61,007,734

4

Consolidated statements of income and consolidated statements of comprehensive income Consolidated statements of income

(Thousands of yen)

Fiscal year ended

Fiscal year ended

September 30, 2020

December 31, 2021

Net sales

13,317,316

34,420,387

Cost of sales

3,825,098

12,951,062

Gross profit

9,492,218

21,469,324

Selling, general and administrative expenses

11,299,938

28,034,551

Operating loss

(1,807,720)

(6,565,226)

Non-operating income

Interest income

2,008

379

Subsidy income

329,227

334,268

Commission income

12,000

45,705

Foreign exchange gains

2,054

5,121

Share of profit of entities accounted for using equity method

-

58,412

Surrender value of insurance policies

-

143,160

Other

43,949

107,706

Total non-operating income

389,239

694,753

Non-operating expenses

Interest expenses

8,957

306,315

Share issuance costs

-

160,160

Share of loss of entities accounted for using equity method

27,492

-

Other

2,759

17,385

Total non-operating expenses

39,208

483,861

Ordinary loss

(1,457,689)

(6,354,334)

Extraordinary income

Gain on reversal of share acquisition rights

1,662

12,296

Gain on sale of non-current assets

365

299

Gain on sale of investment securities

36,278

-

Gain on change in equity

12,856

-

Gain on step acquisitions

-

174,000

Total extraordinary income

51,162

186,596

Extraordinary losses

Loss on sale of non-current assets

-

256

Impairment losses

26,672

54,896

Loss on change in equity

-

5,791

Loss on valuation of investment securities

1,027

42,542

Loss on extinguishment of tie-in shares

-

4,275

Provision for business restructuring

-

461,952

Total extraordinary losses

27,699

569,715

Loss before income taxes

(1,434,226)

(6,737,453)

Income taxes - current

153,443

492,342

Income taxes - deferred

(101,170)

(1,392,464)

Total income taxes

52,272

(900,121)

Loss

(1,486,498)

(5,837,331)

Profit (loss) attributable to non-controlling interests

188

(798,390)

Loss attributable to owners of parent

(1,486,686)

(5,038,941)

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Euglena Co. Ltd. published this content on 22 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 February 2022 06:30:06 UTC.